In addition, in BRCA, COAD, TGCT, KIRC, LIHC, lung cancer, ESCA, OV, and SKCM, the expression of RBM10 in metastatic tumor tissues was markedly increased in comparison with that in the corresponding primary tumor tissues (Figure 1(c)). This evidence concerns the gene RBM10 and lung carcinoma.